BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 25472885)

  • 21. Risk of acute myocardial infarction, stroke, heart failure, and death in elderly Medicare patients treated with rosiglitazone or pioglitazone.
    Graham DJ; Ouellet-Hellstrom R; MaCurdy TE; Ali F; Sholley C; Worrall C; Kelman JA
    JAMA; 2010 Jul; 304(4):411-8. PubMed ID: 20584880
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Association of insurance status and ethnicity with cancer stage at diagnosis for 12 cancer sites: a retrospective analysis.
    Halpern MT; Ward EM; Pavluck AL; Schrag NM; Bian J; Chen AY
    Lancet Oncol; 2008 Mar; 9(3):222-31. PubMed ID: 18282806
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Identifying incident colorectal and lung cancer cases in health service utilisation databases in Australia: a validation study.
    Goldsbury D; Weber M; Yap S; Banks E; O'Connell DL; Canfell K
    BMC Med Inform Decis Mak; 2017 Feb; 17(1):23. PubMed ID: 28241763
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hospital discharges and mortality registries: 2 complementary databases for the epidemiological surveillance of stroke.
    Ramalle-Gomara E; Ruiz E; Serrano M; Bártulos M; González MÁ; Matute B
    J Stroke Cerebrovasc Dis; 2013 Nov; 22(8):e441-5. PubMed ID: 23735373
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Patient time costs associated with cancer care.
    Yabroff KR; Davis WW; Lamont EB; Fahey A; Topor M; Brown ML; Warren JL
    J Natl Cancer Inst; 2007 Jan; 99(1):14-23. PubMed ID: 17202109
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Overall survival and competing risks of death in patients with Waldenström macroglobulinaemia: an analysis of the Surveillance, Epidemiology and End Results database.
    Castillo JJ; Olszewski AJ; Kanan S; Meid K; Hunter ZR; Treon SP
    Br J Haematol; 2015 Apr; 169(1):81-9. PubMed ID: 25521528
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Implantable cardioverter-defibrillators and subsequent cancer risk: a nationwide population-based cohort study.
    Pedersen SB; Nielsen JC; Bøtker HE; Farkas DK; Schmidt M; Sørensen HT
    Europace; 2015 Jun; 17(6):902-8. PubMed ID: 25840286
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Changes in cancer incidence patterns among a northeastern American Indian population: 1955-1969 versus 1990-2004.
    Mahoney MC; Va P; Stevens A; Kahn AR; Michalek AM
    J Rural Health; 2009; 25(4):378-83. PubMed ID: 19780918
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Risk of colorectal cancer in patients with acute myocardial infarction and stroke: a nationwide cohort study.
    Erichsen R; Sværke C; Sørensen HT; Sandler RS; Baron JA
    Cancer Epidemiol Biomarkers Prev; 2013 Nov; 22(11):1994-9. PubMed ID: 24049127
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Association between ischemic stroke and carbon monoxide poisoning: A population-based retrospective cohort analysis.
    Lin CW; Chen WK; Hung DZ; Chen YW; Lin CL; Sung FC; Kao CH
    Eur J Intern Med; 2016 Apr; 29():65-70. PubMed ID: 26703428
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Educational differences in incidence of cancer in Lithuania, 2001-2009: evidence from census-linked cancer registry data.
    Smailyte G; Jasilionis D; Vincerzevskiene I; Krilaviciute A; Ambrozaitiene D; Stankuniene V; Shkolnikov VM
    Eur J Cancer Prev; 2015 May; 24(3):261-6. PubMed ID: 24743349
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of race and ethnicity on outcomes with drug-eluting and bare metal stents: results in 423 965 patients in the linked National Cardiovascular Data Registry and centers for Medicare & Medicaid services payer databases.
    Kumar RS; Douglas PS; Peterson ED; Anstrom KJ; Dai D; Brennan JM; Hui PY; Booth ME; Messenger JC; Shaw RE
    Circulation; 2013 Apr; 127(13):1395-403. PubMed ID: 23547179
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Risk of marrow neoplasms after adjuvant breast cancer therapy: the national comprehensive cancer network experience.
    Wolff AC; Blackford AL; Visvanathan K; Rugo HS; Moy B; Goldstein LJ; Stockerl-Goldstein K; Neumayer L; Langbaum TS; Theriault RL; Hughes ME; Weeks JC; Karp JE
    J Clin Oncol; 2015 Feb; 33(4):340-8. PubMed ID: 25534386
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Occupation and cancer - follow-up of 15 million people in five Nordic countries.
    Pukkala E; Martinsen JI; Lynge E; Gunnarsdottir HK; Sparén P; Tryggvadottir L; Weiderpass E; Kjaerheim K
    Acta Oncol; 2009; 48(5):646-790. PubMed ID: 19925375
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The Impact of the Risk Evaluation Mitigation Strategy for Erythropoiesis-Stimulating Agents on Their Use and the Incidence of Stroke in Medicare Subjects with Chemotherapy-Induced Anemia with Lung and/or Breast Cancers.
    Hollingsworth K; Romney MC; Crawford A; McAna J
    Popul Health Manag; 2016 Feb; 19(1):63-9. PubMed ID: 26102512
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Risks of Venous Thromboembolism, Stroke, Heart Disease, and Myelodysplastic Syndrome Associated With Hematopoietic Growth Factors in a Large Population-Based Cohort of Patients With Colorectal Cancer.
    Du XL; Zhang Y
    Clin Colorectal Cancer; 2015 Dec; 14(4):e21-31. PubMed ID: 26119923
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Recurrent Stroke: The Value of the CHA2DS2VASc Score and the Essen Stroke Risk Score in a Nationwide Stroke Cohort.
    Andersen SD; Gorst-Rasmussen A; Lip GY; Bach FW; Larsen TB
    Stroke; 2015 Sep; 46(9):2491-7. PubMed ID: 26304862
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Recurrent stroke in childhood cancer survivors.
    Fullerton HJ; Stratton K; Mueller S; Leisenring WW; Armstrong GT; Weathers RE; Stovall M; Sklar CA; Goldsby RE; Robison LL; Krull KR
    Neurology; 2015 Sep; 85(12):1056-64. PubMed ID: 26311747
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Racial and ethnic differences in risk of second primary cancers among breast cancer survivors.
    Calip GS; Law EH; Ko NY
    Breast Cancer Res Treat; 2015 Jun; 151(3):687-96. PubMed ID: 26012645
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inverse probability of treatment-weighted competing risks analysis: an application on long-term risk of urinary adverse events after prostate cancer treatments.
    Bolch CA; Chu H; Jarosek S; Cole SR; Elliott S; Virnig B
    BMC Med Res Methodol; 2017 Jul; 17(1):93. PubMed ID: 28693428
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.